The Biology of Allogeneic Hematopoietic Cell Resistance

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 1, 2010, Pages S2-S7

  Shizuru, Judith A ^a   Bhattacharya, Deepta ^a   Cavazzana Calvo, Marina ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CYTOLOGY; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; METHODOLOGY; PHYSIOLOGY; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; STEM CELL NICHE;

ANIMALS; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; SEVERE COMBINED IMMUNODEFICIENCY; STEM CELL NICHE;

MLCS; MLOWN;

EID: 77953035702     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.11.005     Document Type: Article

References (43)

1. Shizuru, J.A., Negrin, R.S., Weissman, I.L., Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med 56 (2005), 509–538.
2. Papayannopoulou, T., Scadden, D.T., Stem-cell ecology and stem cells in motion. Blood 111 (2008), 3923–3930.
3. Jaiswal, S., Jamieson, C.H., Pang, W.W., et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138 (2009), 271–285.
4. Dvorak, C.C., Cowan, M.J., Hematopoietic stem cell transplantation for primary immunodeficiency disease. Bone Marrow Transplant 41 (2008), 119–126.
5. Zimmerman, Z., Jones, M., Shatry, A., Komatsu, M., Mammolenti, M., Levy, R., Cytolytic pathways used by effector cells derived from recipient naive and memory T cells and natural killer cells in resistance to allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 11 (2005), 957–971.
6. Storb, R., Prentice, R.L., Thomas, E.D., et al. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br J Haematol 55 (1983), 573–585.
7. Scheffold, C., Scheffold, Y.C., Cao, T.M., Gworek, J., Shizuru, J.A., Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells. Biol Blood Marrow Transplant 11 (2005), 1–12.
8. Hanash, A.M., Levy, R.B., Donor CD4 + CD25 + T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 105 (2005), 1828–1836.
9. Joffre, O., Santolaria, T., Calise, D., et al. Prevention of acute and chronic allograft rejection with CD4 + CD25 + Foxp3+ regulatory T lymphocytes. Nat Med 14 (2008), 88–92.
10. Shatry, A., Levy, R.B., In situ activation and expansion of host tregs: a new approach to enhance donor chimerism and stable engraftment in major histocompatibility complex-matched allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 15 (2009), 785–794.
11. Taylor, P.A., Panoskaltsis-Mortari, A., Swedin, J.M., et al. L-Selectin(hi) but not the L-selectin(lo) CD4 + 25 + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104 (2004), 3804–3812.
12. Schofield, R., The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4 (1978), 7–25.
13. Bhattacharya, D., Bryder, D., Rossi, D.J., Weissman, I.L., Rapid lymphocyte reconstitution of unconditioned immunodeficient mice with non-self-renewing multipotent hematopoietic progenitors. Cell Cycle 5 (2006), 1135–1139.
14. Bhattacharya, D., Ehrlich, L.I., Weissman, I.L., Space-time considerations for hematopoietic stem cell transplantation. Eur J Immunol 38 (2008), 2060–2067.
15. Prockop, S.E., Petrie, H.T., Regulation of thymus size by competition for stromal niches among early T cell progenitors. J Immunol 173 (2004), 1604–1611.
16. Haug, J.S., He, X.C., Grindley, J.C., et al. N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2 (2008), 367–379.
17. Kiel, M.J., Radice, G.L., Morrison, S.J., Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cell 1 (2007), 204–217.
18. Brecher, G., Ansell, J.D., Micklem, H.S., Tjio, J.H., Cronkite, E.P., Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice. Proc Natl Acad Sci USA 79 (1982), 5085–5087.
19. Saxe, D.F., Boggs, S.S., Boggs, D.R., Transplantation of chromosomally marked syngeneic marrow cells into mice not subjected to hematopoietic stem cell depletion. Exp Hematol 12 (1984), 277–283.
20. Czechowicz, A., Kraft, D., Weissman, I.L., Bhattacharya, D., Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science 318 (2007), 1296–1299.
21. Slavin, S., Nagler, A., Naparstek, E., et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91 (1998), 756–763.
22. Almeida-Porada, G., Flake, A.W., Glimp, H.A., Zanjani, E.D., Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol 27 (1999), 1569–1575.
23. Lazarus, H.M., Koc, O.N., Devine, S.M., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11 (2005), 389–398.
24. Goodman, J.W., Hodgson, G.S., Evidence for stem cells in the peripheral blood of mice. Blood 19 (1962), 702–714.
25. McCredie, K.B., Hersh, E.M., Freireich, E.J., Cells capable of colony formation in the peripheral blood of man. Science 171 (1971), 293–294.
26. Wright, D.E., Wagers, A.J., Gulati, A.P., Johnson, F.L., Weissman, I.L., Physiological migration of hematopoietic stem and progenitor cells. Science 294 (2001), 1933–1936.
27. Bhattacharya, D., Czechowicz, A., Ooi, A.G., Rossi, D.J., Bryder, D., Weissman, I.L., Niche recycling through division-independent egress of hematopoietic stem cells. J Exp Med, 2009.
28. Chen, J., Larochelle, A., Fricker, S., Bridger, G., Dunbar, C.E., Abkowitz, J.L., Mobilization as a preparative regimen for hematopoietic stem cell transplantation. Blood 107 (2006), 3764–3771.
29. Martin, P.J., Hansen, J.A., Buckner, C.D., et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66 (1985), 664–672.
30. Kernan, N.A., Flomenberg, N., Dupont, B., O'Reilly, R.J., Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation 43 (1987), 842–847.
31. Martin, P.J., The role of donor lymphoid cells in allogeneic marrow engraftment. Bone Marrow Transplant 6 (1990), 283–289.
32. Martin, P.J., Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J Exp Med 178 (1993), 703–712.
33. Gandy, K.L., Domen, J., Aguila, H., Weissman, I.L., CD8 + TCR+ and CD8 + TCR− cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity 11 (1999), 579–590.
34. Lapidot, T., Lubin, I., Terenzi, A., Faktorowich, Y., Erlich, P., Reisner, Y., Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity. Proc Natl Acad Sci USA 87 (1990), 4595–4599.
35. Kaufman, C.L., Colson, Y.L., Wren, S.M., Watkins, S., Simmons, R.L., Ildstad, S.T., Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84 (1994), 2436–2446.
36. Taylor, P.A., Ehrhardt, M.J., Lees, C.J., et al. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood 112 (2008), 3508–3516.
37. Antoine, C., Muller, S., Cant, A., et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 361 (2003), 553–560.
38. Gennery AR, Slatter MA, Grandin L, et al. Transplantation of haematopoietic stem cells and long term survival for primary immuneodeficienties in Europe: entering a new century, do we do better? Submitted. 2009.
39. Cavazzana-Calvo, M., Carlier, F., Le Deist, F., et al. Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood 109 (2007), 4575–4581.
40. Straathof, K.C., Rao, K., Eyrich, M., et al. Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study. Lancet 374 (2009), 912–920.
41. Liu, A., Vosshenrich, C.A., Lagresle-Peyrou, C., et al. Competition within the early B-cell compartment conditions B-cell reconstitution after hematopoietic stem cell transplantation in nonirradiated recipients. Blood 108 (2006), 1123–1128.
42. Neven, B., Leroy, S., Decaluwe, H., et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood 113 (2009), 4114–4124.
43. Cavazzana-Calvo, M., Fischer, A., Gene therapy for severe combined immunodeficiency: are we there yet?. J Clin Invest 117 (2007), 1456–1465.